切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2015, Vol. 11 ›› Issue (03) : 301 -305. doi: 10.3877/cma.j.issn.1673-5250.2015.03.004

所属专题: 文献

论著

新疆南疆地区苯丙酮尿症患儿苯丙氨酸羟化酶基因第7,11,12外显子突变研究
王昌敏1,*,*(), 唐承波2, 王慧琴3, 依布拉音3   
  1. 1. 830001 乌鲁木齐,新疆维吾尔自治区人民医院临床检验中心
    2. 834700 新疆维吾尔自治区塔城地区人民医院急救中心
    3. 830001 乌鲁木齐,新疆维吾尔自治区人民医院临床医学研究中心
  • 收稿日期:2014-07-19 修回日期:2015-03-26 出版日期:2015-06-01
  • 通信作者: 王昌敏

Studies on mutations of exon 7, 11, 12 of phenylalanine hydroxylase gene of children with phenylketonuria in the south region of Xinjiang Uygur Autonomous Region

Changmin Wang1(), Chengbo Tang2, Huiqin Wang3, Bulayin Yi3   

  1. 1. Department of Clinical Laboratory Center, People's Hospital of Xingjiang Uygur Autonomous Region, Urumqi 830001, Xingjiang Uygur Autonomous Region, China
    2. Department of Emergency Center, People's Hospital of Tacheng Region, Tacheng 834700, Xingjiang Uygur Autonomous Region, China
    3. Department of Clinical Medicine Research Center, People's Hospital of Xingjiang Uygur Autonomous Region, Urumqi 830001, Xingjiang Uygur Autonomous Region, China
  • Received:2014-07-19 Revised:2015-03-26 Published:2015-06-01
  • Corresponding author: Changmin Wang
  • About author:
    Corresponding author: Wang Changmin, Email:
引用本文:

王昌敏, 唐承波, 王慧琴, 依布拉音. 新疆南疆地区苯丙酮尿症患儿苯丙氨酸羟化酶基因第7,11,12外显子突变研究[J/OL]. 中华妇幼临床医学杂志(电子版), 2015, 11(03): 301-305.

Changmin Wang, Chengbo Tang, Huiqin Wang, Bulayin Yi. Studies on mutations of exon 7, 11, 12 of phenylalanine hydroxylase gene of children with phenylketonuria in the south region of Xinjiang Uygur Autonomous Region[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2015, 11(03): 301-305.

目的

探讨新疆南疆地区苯丙酮尿症(PKU)患儿苯丙氨酸羟化酶(PAH)基因第7,11,12外显子突变特征。

方法

选择2009年3月至2013年12月在新疆南疆地区,经各级医疗机构确诊的42例PKU患儿(均于新生儿PKU筛查时即被确诊)为研究对象,采集其足跟血或静脉血,采用聚合酶链反应(PCR)产物直接测序法进行PAH基因第7,11,12外显子的基因突变分析。本研究遵循的程序符合新疆维吾尔自治区人民医院等各级医疗机构人体试验委员会制定的伦理学标准,得到该委员会批准,征得受试对象或其监护人知情同意,并与监护人签署临床研究知情同意书。

结果

在42例患儿的42对PAH等位基因中,检测出7种PAH基因突变类型,共计46个PAH基因突变位点,其分别为:23个第7外显子c.735G>A(p.Val245Val)静默突变位点;8个第7外显子c.728G>A(p.Arg243Gln)错义突变位点;2个第7外显子c.781C>T(p.Arg261X)无义突变位点;1个第7外显子c.782G>A(p.Arg261Gln)错义突变位点;6个第11外显子c.1155G>C(p.Leu385Leu)静默突变位点;5个第12外显子c.1238G>C(p.Arg413Pro)错义突变位点及1个第12外显子c.1252A>C(p.Thr418Pro)错义突变位点。其中,第7外显子c.735G>A(p.Val245Val)突变位点占此次检出突变位点比例最高,为50.00%(23/46),其突变频率为27.38%(23/84)。PAH基因的等位基因突变检出率为54.76%(46/84)。

结论

新疆南疆地区PKU患儿PAH基因第7,11,12外显子的突变特征为:静默突变和错义突变为主要突变,第7外显子出现的突变类型和数量最多。

Objective

To study the characteristics of mutations of exon 7, 11, 12 in phenylalanine hydroxylase(PAH) gene of children with phenylketonuria(PKU) in south region of Xinjiang Uygur Autonomous Region.

Methods

A total of 42 children who made a definite diagnosis as PKU by different levels of medical institutions in the south region of Xinjiang by neonatal PKU screening from March 2009 to December 2013 were chosen as study subjects.The mutations of exon 7, 11, 12 of PAH gene were analyzed by detect heelstick blood or venous blood through polymerase chain reaction(PCR) and PAH gene DNA sequencing.The study protocol was approved by the Ethical Review Board of Investigation in Human Being of different levels of medical institutions in the south region of Xinjiang Uygur Autonomous Region, such as People's Hospital of Xingjiang Uygur Autonomous Region.Informed consent was obtained from the parents of each participant.

Results

There were 7 types of mutation of PAH gene, and a total of 46 mutational sites were detected in 42 pairs of PAH alleles in 42 PKU children.There were 23 silent mutations of exon 7: c. 735G>A(p.Val245Val), 8 missense mutations of exon 7: c.728G>A(p.Arg243Gln), 2 nonsense mutations of exon 7: c. 781C>T(p.Arg261X), 1 missense mutations of exon 7: c.782G>A(p.Arg261Gln), 6 silent mutations of exon 11: c.1155G>C (p.Leu385Leu), 5 missense mutations of exon 12: c.1238G>C(p.Arg413Pro) and 1 missense mutation of exon 12: c.1252A>C(p.Thr418Pro). The exon 7: c.735G>A(p.Val245Val) mutational site has the highest detection ratio [50.00%(23/46)] in this study, and the mutation frequency was 27.38%(23/84). Mutation detection rate of PAH alleles was 54.76%(46/84).

Conclusions

The mutational characteristic in exon 7, 11, 12 of PAH gene in PKU children in south region of Xinjiang is silent mutational and missense mutation are major mutation types, and mutation types and amount of exon 7 are the most frequent.

图1 34例PKU患儿PAH基因第7外显子PCR扩增1%琼脂糖凝胶电泳图
Figure 1 1% agarose gel electrophoretogram of PCR amplification on exon7 of PAH gene in 34 case of PKU children
表1 PAH基因第7,11,12外显子PCR引物序列
Table 1 PCR primer sequences of exon 7,11,12 of PAH gene
图2 南疆地区PKU患儿与基因库PAH基因DNA序列(gi:209364518)(http://www.pahdb.mcgill.ca/)第7,11,12外显子测序结果比较
Figure 2 Comparison of exon7,11,12 of PAH gene DNA sequencing results between PKU children in south region of Xinjiang and gene bank(gi:209364518)(http://www.pahdb.mcgill.ca/)
表2 42例新疆南疆地区PKU患儿PAH基因突变类型及频率
Table 2 The mutation type and frequency of PAH gene in 42 children with PKU in the south region of Xinjiang
[1]
顾学范,王治国.中国580万新生儿苯丙酮尿症和先天性甲状腺功能减低症的筛查[J].中华预防医学杂志,2004,38(2):99–102.
[2]
谢雯.浅谈苯丙酮尿症[J].科技信息,2011,(13):814–815.
[3]
王昌敏,王慧琴,张慧.新疆南疆地区2009-2013年新生儿疾病筛查结果分析[J].实用预防医学,2015,22(1):72–74.
[4]
乔晓亮.2009-2013年郑州市新生儿苯丙酮尿症和先天性甲状腺功能减低症发病情况分析[J].中国妇幼保健,2015,30(2):234–236.
[5]
杨曦,何江,余伍忠,等.新疆94 951例新生儿疾病筛查及随访结果分析[J].临床儿科杂志,2015,33(1):92–93.
[6]
王慧琴,计燕萍,王昌敏,等.新疆南疆地区146 092例新生儿苯丙酮尿症筛查结果分析[J].中国优生与遗传杂志,2014,22(9):108–112.
[7]
何美丽,李娜,樊静,等.新生儿苯丙酮尿症、先天性甲状腺功能低下筛查分析(附38 286例报告)[J].北京医学,2014,36(4):275–277.
[8]
王惠珍,徐发亮,陈舒清,等.青海省115 524例不同民族新生儿疾病筛查结果分析[J].中国妇幼保健,2014,29(29):4804–4806.
[9]
余伍忠,仇东辉,何江,等.新疆地区苯丙酮尿症PAH基因新突变鉴定[J].解放军医学杂志,2010,35(12):1506–1507.
[10]
杨树法,赵娟,王琳琳.苯丙氨酸羟化酶基因突变研究进展[J].检验医学与临床,2012,9(9):1097–1099.
[11]
周忠蜀,李鹏.苯丙酮尿症的诊断和治疗进展[J].北京医学,2014,36(4):250–252.
[12]
孙云,张菁菁,孙亦骏,等.苯丙氨酸羟化酶缺乏症基因型与表型的关系[J].临床儿科杂志,2014,32(1):33–37.
[13]
毛丹丹,傅咏南,王校,等.苯丙酮尿症基因诊断研究方法[J].中国优生优育,2013,19(8): 648–652.
[14]
强荣,余伍忠,蔡娜,等.陕西地区苯丙酮尿症患儿苯丙氨酸羟化酶基因突变研究[J].中华医学遗传学杂志,2014,31(1):74–77.
[15]
毛新梅,何江,刘媛,等.宁夏地区回族苯丙酮尿症患儿苯丙氨酸羟化酶基因突变分析[J].中华临床医师杂志:电子版,2012,6(21):6784–6787.
[1] 铁晓玲, 刘毅, 杨颖, 车凤玉. Rubinstein-Taybi综合征先证者3例并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 452-459.
[2] 张学. 说基因话疾病[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 366-.
[3] 王莉, 曹蕾, 王亚丹, 张伟. Krabbe病1例临床分析并文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 339-345.
[4] 黄莹, 李璇, 刘梦杨, 彭桂林, 徐鑫, 韦兵, 杨超. 靶向联合治疗双肺移植术后KRAS和BRAF基因双突变晚期肺腺癌一例[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 298-301.
[5] 刘云, 时月, 郭冬梅, 邱志远, 王丽娟, 冉学红, 李乾鹏. 造血干细胞移植治疗伴有胚系突变的髓系肿瘤患者三例并文献复习[J/OL]. 中华移植杂志(电子版), 2024, 18(04): 230-234.
[6] 谭智勇, 付什, 李宁, 王海峰, 王剑松. 膀胱小细胞癌发病机制及其诊疗研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(02): 183-187.
[7] 赖淼, 景鑫, 李桂珍, 李怡. 非小细胞肺癌EGFR 突变亚型的临床病理和预后意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 731-737.
[8] 郑琪, 马婕群, 张彦兵, 廖子君, 张锐. EPHA5突变预测肺腺癌免疫检查点抑制剂治疗预后的临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 548-552.
[9] 李静静, 许金花, 吴国峰, 任亚俊, 张骞云. 伏美替尼一线治疗EGFR突变晚期NSCLC脑转移的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 426-429.
[10] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[11] 刘洋, 吴涛, 刘恒, 刘文慧, 田红娟, 周芮, 高铭敏, 王向丽, 张睿. 异基因造血干细胞移植治疗CSF3R基因突变急性髓系白血病M2型1例并文献复习[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(02): 90-92.
[12] 惠泉, 孙方昱, 赵欣, 许青, 李奕, 陈建雄, 吴立, 郑伟燕. 急性间歇性卟啉病HMBS基因新发缺失突变一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 507-511.
[13] 李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
[14] 张冬雷, 刘晓燕, 吴三云, 周怡, 张岘. 一例遗传性凝血因子Ⅻ缺乏症家系报道及中国人群凝血因子Ⅻ缺乏症分析[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(03): 162-169.
[15] 张滕, 陶艳玲. Shwachman-Diamond综合征继发骨髓增生异常综合征一例及文献复习[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 178-182.
阅读次数
全文


摘要